Sonoma Pharmaceuticals (SNOA) Income from Non-Controlling Interests (2020 - 2021)
Sonoma Pharmaceuticals (SNOA) posted Income from Non-Controlling Interests of $1.0 million for Q4 2021, up 202.1% on a QoQ basis from $334000.0 in Q3 2021, and up 372.7% year-over-year from $213453.4 in Q4 2020.
Powered by 
Analysis
Sonoma Pharmaceuticals (SNOA) Income from Non-Controlling Interests (2020 - 2021) Analysis & Trends
Sonoma Pharmaceuticals has reported Income from Non-Controlling Interests for 2 years, with the latest figure at $1.0 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.49 Bn | 48.62 Bn | 2.32 Bn | - |
| 2 | Medline | 29.39 Bn | 26.71 Bn | 2.22 Bn | 79.00 Mn |
| 3 | West Pharmaceutical Services | 24.03 Bn | 23.59 Bn | 329.20 Mn | - |
| 4 | Baxter International | 12.81 Bn | 10.66 Bn | 1.03 Bn | - |
| 5 | Stevanato Group S.p.A | 5.52 Bn | 5.41 Bn | 100.91 Mn | -3,487.09 |
| 6 | Acme United | 233.44 Mn | 228.40 Mn | 26.69 Mn | - |
| 7 | Rockwell Medical | 31.09 Mn | 6.29 Mn | 3.24 Mn | - |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | - |
| 9 | United Health Products | 8.37 Mn | 8.34 Mn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 334,000.00 |
| Jun 30, 2021 | 791,000.00 |
| Dec 31, 2020 | -370,000.00 |
| Sep 30, 2020 | -308,000.00 |
| Jun 30, 2020 | -407,000.00 |